The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
The Magic of Randomization versus the Myth of Real-World Evidence
Abstract
Nonrandomized observational analyses have been promoted as alternatives to randomized clinical trials. However, randomization ensures balance between groups, whereas nonrandomized studies are often biased by between-group differences. Efforts to reduce the cost and complexity of clinical trials are preferable to relying on observational studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Perkovic, V., Jardine, M. J., Neal, B., Bompoint, S., Heerspink, H. J. L., Charytan, D. M., Edwards, R., Agarwal, R., Bakris, G., Bull, S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1811744 · Cited by 6,189
Evaluating non-randomised intervention studies
Deeks, J., Dinnes, J., D'Amico, R., Sowden, A., Sakarovitch, C., Song, F., Petticrew, M., & Altman, D. (2003) · Health Technology Assessment · doi:10.3310/hta7270 · Cited by 2,907
Interpretation of the evidence for the efficacy and safety of statin therapy
Collins, R., Reith, C., Emberson, J., Armitage, J., Baigent, C., Blackwell, L., Blumenthal, R., Danesh, J., Smith, G. D., DeMets, D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31357-5 · Cited by 1,857
Self-citationEffects of anacetrapib in patients with atherosclerotic vascular disease
The HPS3/TIMI55–REVEAL Collaborative Group (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1706444 · Cited by 1,047
Statin use and reduced cancer-related mortality
Nielsen, S. F., Nordestgaard, B. G., & Bojesen, S. E. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1201735 · Cited by 1,030
Comparison of Evidence of Treatment Effects in Randomized and Nonrandomized Studies
Ioannidis, J. P. A. (2001) · JAMA · doi:10.1001/jama.286.7.821 · Cited by 919
The Impact of Residual and Unmeasured Confounding in Epidemiologic Studies: A Simulation Study
Fewell, Z., Davey Smith, G., & Sterne, J. A. C. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm165 · Cited by 734
When are randomised trials unnecessary? Picking signal from noise
Glasziou, P., Chalmers, I., Rawlins, M., & McCulloch, P. (2007) · BMJ · doi:10.1136/bmj.39070.527986.68 · Cited by 589
Kim, E. S., Bruinooge, S. S., Roberts, S., Ison, G., Lin, N. U., Gore, L., Uldrick, T. S., Lichtman, S. M., Roach, N., Beaver, J. A., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.73.7916 · Cited by 485
Real-world evidence and real-world data for evaluating drug safety and effectiveness.
Corrigan-Curay, J., Sacks, L., & Woodcock, J. (2018) · JAMA · doi:10.1001/jama.2018.10136 · Cited by 471
Credibility of claims of subgroup effects in randomised controlled trials: systematic review
Sun, X., Briel, M., Busse, J. W., You, J. J., Akl, E. A., Mejza, F., Bala, M. M., Bassler, D., Mertz, D., Diaz-Granados, N., et al. (2012) · BMJ · doi:10.1136/bmj.e1553 · Cited by 395
Bosco, J. L. F., Silliman, R. A., Thwin, S. S., Geiger, A. M., Buist, D. S. M., Prout, M. N., Yood, M. U., Haque, R., Wei, F., & Lash, T. L. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.03.001 · Cited by 394
Registry-based randomized clinical trials—a new clinical trial paradigm
James, S., Rao, S. V., & Granger, C. B. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.33 · Cited by 331
When and how can real world data analyses substitute for randomized controlled trials?
Franklin, J. M., & Schneeweiss, S. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.857 · Cited by 316
Ford, I., Murray, H., McCowan, C., & Packard, C. J. (2016) · Circulation · doi:10.1161/circulationaha.115.019014 · Cited by 238
Limits of observational data in determining outcomes from cancer therapy
Giordano, S. H., Kuo, Y., Duan, Z., Hortobagyi, G. N., Freeman, J., & Goodwin, J. S. (2008) · Cancer · doi:10.1002/cncr.23452 · Cited by 206
Ensuring trial validity by data quality assurance and diversification of monitoring methods
Baigent, C., Harrell, F. E., Buyse, M., Emberson, J. R., & Altman, D. G. (2008) · Clinical Trials · doi:10.1177/1740774507087554 · Cited by 163
Randomized Clinical Trials — Removing Unnecessary Obstacles
Reith, C. A., Landray, M., Devereaux, P. J., Bosch, J., Granger, C. B., Baigent, C., Califf, R. M., Collins, R., & Yusuf, S. (2013) · New England Journal of Medicine · doi:10.1056/nejmsb1300760 · Cited by 123
Self-citationEvaluating the benefit of event adjudication of cardiovascular outcomes in large simple RCTs
Pogue, J. M., Walter, S. D., & Yusuf, S. (2009) · Clinical Trials · doi:10.1177/1740774509105223 · Cited by 114
Equipoise Lost: Ethics, Costs, and the Regulation of Cancer Clinical Research
Stewart, D. J., Whitney, S. N., & Kurzrock, R. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.5404 · Cited by 109
The imperative of overcoming barriers to the conduct of large, simple trials.
Eapen, Z. J., Lauer, M. S., & Temple, R. J. (2014) · JAMA · doi:10.1001/jama.2014.1030 · Cited by 89
Oversight of clinical investigations- A risk based approach to monitoring
Obied, T. (2014) · Pharmaceutical Regulatory Affairs Open Access · Cited by 87
Bakobaki, J. M., Rauchenberger, M., Joffe, N., McCormack, S., Stenning, S. P., & Meredith, S. K. (2011) · Clinical Trials · doi:10.1177/1740774511427325 · Cited by 85
Use of Medicare Data to Identify Coronary Heart Disease Outcomes in the Women’s Health Initiative
Hlatky, M. A., Ray, R. M., Burwen, D. R., Margolis, K. L., Johnson, K., Kucharska‐Newton, A., Manson, J. E., Robinson, J. G., Safford, M. M., Allison, M., et al. (2014) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.113.000373 · Cited by 84
Enhancing clinical evidence by proactively building quality into clinical trials
Meeker-O’Connell, A., Glessner, C., Behm, M., Mulinde, J., Roach, N., Sweeney, F., Tenaerts, P., & Landray, M. (2016) · Clinical Trials · doi:10.1177/1740774516643491 · Cited by 70
Self-citationNdounga‐Diakou, L. A., Trinquart, L., Hróbjartsson, A., Barnes, C., Yavchitz, A., Ravaud, P., & Boutron, I. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000043.pub2 · Cited by 57
Lindblad, A. S., Manukyan, Z., Purohit-Sheth, T., Gensler, G. R., Okwesili, P., Meeker-O’Connell, A., Ball, L. K., & Marler, J. R. (2013) · Clinical Trials · doi:10.1177/1740774513508028 · Cited by 53
Applying results from clinical trials: tranexamic acid in trauma patients
Roberts, I., & Prieto‐Merino, D. (2014) · Journal of Intensive Care · doi:10.1186/s40560-014-0056-1 · Cited by 38
Improving public health by improving clinical trial guidelines and their application
Landray, M., Bax, J. J., Alliot, L., Buyse, M. E., Cohen, A. F., Collins, R., Hindricks, G., James, S. K., Lane, S., Maggioni, A. P., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx086 · Cited by 26
Self-citationIncreasing the use of mobile technology–derived endpoints in clinical trials
Herrington, W. G., Goldsack, J. C., & Landray, M. (2018) · Clinical Trials · doi:10.1177/1740774518755393 · Cited by 24
Self-citationPCSK9 Inhibition to Reduce Cardiovascular Risk
Waters, D. D., & Hsue, P. Y. (2017) · Circulation Research · doi:10.1161/circresaha.117.311015 · Cited by 17
Cited by
Dexamethasone in Hospitalized Patients with Covid-19
The RECOVERY Collaborative Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021436 · Cited by 11,477
Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report
Horby, P., Lim, W. S., Emberson, J., Mafham, M., Bell, J., Linsell, L., Staplin, N., Brightling, C., Ustianowski, A., Elmahi, E., et al. (2020) · doi:10.1101/2020.06.22.20137273 · Cited by 11,475
Self-citationPan, H., Peto, R., Henao Restrepo, A. M., Preziosi, M.-P., Sathiyamoorthy, V., Karim, Q. A., Alejandria, M., Hernàndez García, C., Kieny, M.-P., Malekzadeh, R., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00519-0 · Cited by 394
Self-citationSARS-CoV-2 Variants and Vaccines
Krause, P. R., Fleming, T. R., Longini, I. M., Peto, R., Briand, S., Heymann, D. L., Beral, V., Snape, M. D., Rees, H., Ropero, A.-M., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmsr2105280 · Cited by 366
Self-citationUsing Mendelian Randomization to Improve the Design of Randomized Trials
Ference, B. A., Holmes, M. V., & Smith, G. D. (2021) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a040980 · Cited by 338
Metadata
- Authors
- Collins, R., Bowman, L., Landray, M., & Peto, R.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2020-02-13
- Volume
- 382
- Issue
- 7
- Pages
- 674-678
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W3006019089
- Cited by
- 478
- References
- 32
- FWCI
- 53.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.